W

Waypoint Bio

HealthCAR-T Therapy📍 China

Waypoint Bio is a biotechnology company focused on developing innovative CAR-T therapies. The company aims to address unmet medical needs in cancer treatment through its clinical trials in China. This funding will support the execution of three CAR-T trials, highlighting the company's commitment to advancing cancer therapies.

Visit website ↗
Total raised
$20M
tracked to date
Latest round
$20M
May 27, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups in China.

Claim this profile →

Funding history

  1. 1
    $20MMay 27, 2026
    Announcement ↗

Waypoint Bio in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile